Lineage Cell Therapeutics, Inc. Common Stock (NY:LCTX)
1.260
-0.050
(-3.82%)
Streaming Delayed Price
Updated: 3:46 PM EDT, May 15, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 916,361 |
| Open | 1.260 |
| Bid (Size) | 1.260 (5,900) |
| Ask (Size) | 1.270 (6,900) |
| Prev. Close | 1.310 |
| Today's Range | 1.230 - 1.279 |
| 52wk Range | 0.4501 - 2.090 |
| Shares Outstanding | 174,986,671 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Lineage Announces Formation of Scientific Advisory Board
April 13, 2026
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Lineage Cell Therapeutics Issues Letter to Stockholders
January 05, 2026
12 Health Care Stocks Moving In Monday's After-Market Session ↗
September 22, 2025
Lineage Cell Therapeutics to Present at September 2025 Investor Conferences
September 02, 2025
12 Health Care Stocks Moving In Friday's Intraday Session ↗
August 15, 2025
Lineage Cell Revenue Doubles in Q2 ↗
August 12, 2025
Earnings Scheduled For August 12, 2025 ↗
August 12, 2025
Frequently Asked Questions
Is Lineage Cell Therapeutics, Inc. Common Stock publicly traded?
Yes, Lineage Cell Therapeutics, Inc. Common Stock is publicly traded.
What exchange does Lineage Cell Therapeutics, Inc. Common Stock trade on?
Lineage Cell Therapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Lineage Cell Therapeutics, Inc. Common Stock?
The ticker symbol for Lineage Cell Therapeutics, Inc. Common Stock is LCTX on the New York Stock Exchange
What is the current price of Lineage Cell Therapeutics, Inc. Common Stock?
The current price of Lineage Cell Therapeutics, Inc. Common Stock is 1.260
When was Lineage Cell Therapeutics, Inc. Common Stock last traded?
The last trade of Lineage Cell Therapeutics, Inc. Common Stock was at 05/15/26 03:46 PM ET
What is the market capitalization of Lineage Cell Therapeutics, Inc. Common Stock?
The market capitalization of Lineage Cell Therapeutics, Inc. Common Stock is 220.48M
How many shares of Lineage Cell Therapeutics, Inc. Common Stock are outstanding?
Lineage Cell Therapeutics, Inc. Common Stock has 220M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.